Evidence map›Paper›PMID 27629550›Full record

ArticleBlood2016

Whole exome sequencing in families with CLL detects a variant in Integrin β 2 associated with disease susceptibility.

Lynn R Goldin, Mary L McMaster, Melissa Rotunno, Sarah E M Herman, Kristine Jones, Bin Zhu, Joseph Boland, Laurie Burdett, Belynda Hicks, Sarangan Ravichandran and 9 more

Registry-linked trialOpen access · bronzeAbstract readLetter
In one paragraph

Article in Blood, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT00039676 (Clinical, Laboratory, and Epidemiologic Characterization of Individuals and Families at High Risk of Blood and Lymph Node Malignancy), which is not on this map. Cited by 14 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed, 1 pooled it
1.4field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT00039676 active not recruitingnot on this map

Clinical, Laboratory, and Epidemiologic Characterization of Individuals and Families at High Risk of Blood and Lymph Node Malignancy

TypeobservationalSponsorNational Cancer Institute (NCI)Ran2002Enrolled1,836ConditionsWaldenstrom Macroglobulinemia, Chronic Lymphocytic Leukemia, Hodgkin Disease, NonHodgkin Lymphoma
3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 1 synthesis or guideline pooled it, 18 citations in OpenAlex.

  1. A Systematic Literature Review of Whole Exome and Genome Sequencing Population Studies of Genetic Susceptibility to Cancer.Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology · 2020
    Pooled it
  2. Clinical Risks for Chronic Lymphocytic Leukemia.Journal of the National Comprehensive Cancer Network : JNCCN · 2024
    Review
  3. Haematologica · 2024
    Article
  4. Review
  5. Article
  6. Article
  7. β2 Integrins-Multi-Functional Leukocyte Receptors in Health and Disease.International journal of molecular sciences · 2020
    Review
  8. Article
  9. Chronic lymphocytic leukaemia: from genetics to treatment.Nature reviews. Clinical oncology · 2019
    Review
  10. Article
  11. Article
  12. Analysis ofBlood · 2017
    Article
  13. Review
  14. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

19 authors at 8 institutions in 1 country.

Lynn R GoldinGenetic Epidemiology Branch, Division of Cancer Epidemiology and Genetics.
Mary L McMasterGenetic Epidemiology Branch, Division of Cancer Epidemiology and Genetics.
Melissa RotunnoEpidemiology and Genomics Research Program, Division of Cancer Control and Population Sciences, National Cancer Institute, National Institutes of Health (NIH), Bethesda, MD.
Sarah E M HermanHematology Branch, National Heart, Lung and Blood Institute, NIH, Bethesda, MD.
Kristine JonesCancer Genomics Research Laboratory, Division of Cancer Epidemiology and Genetics, National Cancer Institute, NIH, Bethesda, MD.
Bin ZhuCancer Genomics Research Laboratory, Division of Cancer Epidemiology and Genetics, National Cancer Institute, NIH, Bethesda, MD.
Joseph BolandCancer Genomics Research Laboratory, Division of Cancer Epidemiology and Genetics, National Cancer Institute, NIH, Bethesda, MD.
Laurie BurdettCancer Genomics Research Laboratory, Division of Cancer Epidemiology and Genetics, National Cancer Institute, NIH, Bethesda, MD.
Belynda HicksCancer Genomics Research Laboratory, Division of Cancer Epidemiology and Genetics, National Cancer Institute, NIH, Bethesda, MD.
Sarangan RavichandranAdvanced Biomedical Computing Center, Frederick National Laboratory for Cancer Research, Frederick, MD.
Brian T LukeAdvanced Biomedical Computing Center, Frederick National Laboratory for Cancer Research, Frederick, MD.
Meredith YeagerCancer Genomics Research Laboratory, Division of Cancer Epidemiology and Genetics, National Cancer Institute, NIH, Bethesda, MD.
Laura FontaineWestat, Inc, Rockville, MD.
Alisa M GoldsteinGenetic Epidemiology Branch, Division of Cancer Epidemiology and Genetics.
Stephen J ChanockDivision of Cancer Epidemiology and Genetics, and.
Margaret A TuckerHuman Genetics Program, Division of Cancer Epidemiology and Genetics, National Cancer Institute, NIH, Bethesda, MD; and.
Adrian WiestnerHematology Branch, National Heart, Lung and Blood Institute, NIH, Bethesda, MD.
Gerald MartiCenter for Devices and Radiological Health, US Food and Drug Administration, Silver Spring, MD.
Neil E CaporasoGenetic Epidemiology Branch, Division of Cancer Epidemiology and Genetics.
National Cancer Institute · USDivision of Cancer Epidemiology and GeneticsCancer Genetics (United States) · USFrederick National Laboratory for Cancer Research · USNational Heart Lung and Blood Institute · USNational Institutes of Health · USUnited States Food and Drug Administration · USWestat (United States) · US

Funding

Family Studies ZIACP004410 · NCI · DIVISION OF CANCER EPIDEMIOLOGY AND GENETICS · PI SAVAGE, SHARON A. · 2009 to 2025
$56.1M
NCI NIH HHS HHSN261200800001E
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Genetic Predisposition to DiseaseMutation, MissenseCase-Control StudiesCD18 AntigensExome SequencingFamilyFemaleGenetic TestingHumansLeukemia, Lymphocytic, Chronic, B-CellMaleNuclear ProteinsCD18 AntigensNuclear ProteinsSwi5 protein, human

Identifiers

PMID27629550
PMCPMC5095758
OpenAlexW2520601012

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.